Characterisation of Pseudomonas aeruginosa related to bovine mastitis
- PMID: 24334080
- DOI: 10.1556/AVet.2013.054
Characterisation of Pseudomonas aeruginosa related to bovine mastitis
Abstract
Pseudomonas aeruginosa is one of the causative pathogens of bovine mastitis. Most P. aeruginosa strains possess the type III secretion system (TTSS), which may increase somatic cell counts (SCCs) in milk from mastitis-affected cows. Moreover, most of P. aeruginosa cells can form biofilms, thereby reducing antibiotic efficacy. In this study, the presence and effect of TTSS-related genotypes on increase of SCCs among 122 P. aeruginosa isolates obtained from raw milk samples from mastitis-affected cows and their antibiotic susceptibility at planktonic and biofilm status were investigated. Based on the presence of TTSS-related genes a total of 82.7% of the isolates were found to harbour exoU and/or exoS genes, including the invasive (exoU-/exoS+, 69.4%), cytotoxic (exoU+/exoS-, 8.3%) and cytotoxic/invasive strains (exoU+/ exoS+, 5.0%). Milk containing exoS-positive isolates had higher SCCs than those containing exoS-negative isolates. The majority of isolates showed gentamicin, amikacin, meropenem and ciprofloxacin susceptibility at planktonic status. However, the susceptibility was decreased at the biofilm status. Based on minimum biofilm eradication concentration (MBEC)/minimum inhibitory concentration (MIC) ratios, the range of change in antibiotic susceptibility varied widely depending on the antibiotics (from ≥ 3.1-fold to ≥ 475.0-fold). In conclusion, most P. aeruginosa isolates studied here had a genotype related to increase in SCCs. The efficiency of antibiotic therapy against P. aeruginosa-related bovine mastitis could be improved by analysing both the MBEC and the MIC of isolates.
Keywords: Pseudomonas aeruginosa; biofilm; bovine mastitis; minimum biofilm eradication concentration (MBEC); type three secretion system (TTSS).
Similar articles
-
Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.Burns. 2012 Dec;38(8):1192-7. doi: 10.1016/j.burns.2012.07.030. Epub 2012 Sep 17. Burns. 2012. PMID: 22995427
-
Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.Auris Nasus Larynx. 2017 Jun;44(3):258-265. doi: 10.1016/j.anl.2016.07.005. Epub 2016 Jul 25. Auris Nasus Larynx. 2017. PMID: 27461174
-
The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.Int J Mol Cell Med. 2015 Summer;4(3):167-73. Int J Mol Cell Med. 2015. PMID: 26629485 Free PMC article.
-
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.Crit Care. 2014 Dec 13;18(6):668. doi: 10.1186/s13054-014-0668-9. Crit Care. 2014. PMID: 25672496 Free PMC article. Review.
-
ExoU is a potent intracellular phospholipase.Mol Microbiol. 2004 Sep;53(5):1279-90. doi: 10.1111/j.1365-2958.2004.04194.x. Mol Microbiol. 2004. PMID: 15387809 Review.
Cited by
-
Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals.BMC Microbiol. 2019 Jun 17;19(1):134. doi: 10.1186/s12866-019-1481-z. BMC Microbiol. 2019. PMID: 31208333 Free PMC article.
-
New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient.Antibiotics (Basel). 2021 Apr 23;10(5):491. doi: 10.3390/antibiotics10050491. Antibiotics (Basel). 2021. PMID: 33922748 Free PMC article.
-
Characterization of rumen, fecal, and milk microbiota in lactating dairy cows.Front Microbiol. 2022 Sep 26;13:984119. doi: 10.3389/fmicb.2022.984119. eCollection 2022. Front Microbiol. 2022. PMID: 36225385 Free PMC article.
-
Antimicrobial and Antibiofilm Capacity of Chitosan Nanoparticles against Wild Type Strain of Pseudomonas sp. Isolated from Milk of Cows Diagnosed with Bovine Mastitis.Antibiotics (Basel). 2020 Aug 28;9(9):551. doi: 10.3390/antibiotics9090551. Antibiotics (Basel). 2020. PMID: 32872146 Free PMC article.
-
Dilution Reduces Sample Matrix Effects for Rapid, Direct, and Miniaturised Phenotypic Antibiotic Susceptibility Tests for Bovine Mastitis.Antibiotics (Basel). 2023 Aug 24;12(9):1363. doi: 10.3390/antibiotics12091363. Antibiotics (Basel). 2023. PMID: 37760660 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources